We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+6.83%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.1B
AUM Growth
+$2.29B
(+14%)
Cap. Flow
+$1.49B
Cap. Flow
% of AUM
8.21%
Top 10 Holdings %
Top 10 Hldgs %
14.26%
Holding
1,826
New
616
Increased
338
Reduced
371
Closed
491
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$219M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$207M |
| 3 |
Quest Diagnostics
DGX
|
+$161M |
| 4 |
CVS Health
CVS
|
+$154M |
| 5 |
PG&E
PCG
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$162M |
| 2 |
Texas Instruments
TXN
|
+$103M |
| 3 |
Amazon
AMZN
|
+$85.6M |
| 4 |
Delta Air Lines
DAL
|
+$76M |
| 5 |
NVIDIA
NVDA
|
+$75.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.56% |
| 2 | Technology | 14.21% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Industrials | 10.91% |
| 5 | Communication Services | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRKL
1226
DELISTED
Brookline Bancorp
BRKL
| $303K | ﹤0.01% |
19,323
-44,163
| -70% | -$689K |
|
|
LX
1227
LexinFintech Holdings
LX
$239M
| $296K | ﹤0.01% |
+21,264
| New | +$281K |
|
1228
Highwoods Properties
HIW
$3.47B
| $295K | ﹤0.01% |
+5,785
| New | +$298K |
|
1229
Sixth Street Specialty
TSLX
$1.78B
| $295K | ﹤0.01% |
+14,885
| New | +$305K |
|
1230
Sibanye-Stillwater
SBSW
$7B
| $288K | ﹤0.01% |
59,225
-177,092
| -75% | -$860K |
|
1231
Bankunited
BKU
$3.37B
| $287K | ﹤0.01% |
+7,048
| New | +$257K |
|
|
XENT
1232
DELISTED
Intersect ENT, Inc
XENT
| $287K | ﹤0.01% |
+8,885
| New | +$266K |
|
|
SN
1233
DELISTED
Sanchez Energy Corporation
SN
| $282K | ﹤0.01% |
+53,204
| New | +$252K |
|
|
WP
1234
DELISTED
Worldpay, Inc.
WP
| $281K | ﹤0.01% |
3,822
-96,191
| -96% | -$6.87M |
|
1235
Enova International
ENVA
$6.37B
| $280K | ﹤0.01% |
18,406
-292,756
| -94% | -$4.3M |
|
|
WES
1236
DELISTED
Western Gas Partners Lp
WES
| $279K | ﹤0.01% |
5,810
-329,311
| -98% | -$15.7M |
|
1237
Chord Energy
CHRD
$7.46B
| $277K | ﹤0.01% |
+32,879
| New | +$303K |
|
|
CCEC
1238
Capital Clean Energy Carriers
CCEC
$1.37B
| $276K | ﹤0.01% |
+11,747
| New | +$276K |
|
|
SCG
1239
DELISTED
Scana
SCG
| $276K | ﹤0.01% |
6,948
-362,102
| -98% | -$16.2M |
|
|
EVA
1240
DELISTED
Enviva Inc.
EVA
| $274K | ﹤0.01% |
9,893
-2,218
| -18% | -$63.8K |
|
|
CRCM
1241
DELISTED
CARE.COM, INC.
CRCM
| $274K | ﹤0.01% |
+15,164
| New | +$265K |
|
1242
Assembly Biosciences
ASMB
$524M
| $273K | ﹤0.01% |
+503
| New | +$228K |
|
1243
SK Telecom
SKM
$13.7B
| $270K | ﹤0.01% |
5,865
-86,093
| -94% | -$3.76M |
|
|
NAV
1244
DELISTED
Navistar International
NAV
| $270K | ﹤0.01% |
+6,284
| New | +$261K |
|
1245
Toll Brothers
TOL
$14.1B
| $269K | ﹤0.01% |
+5,610
| New | +$258K |
|
|
CRHM
1246
DELISTED
CRH Medical Corporation
CRHM
| $268K | ﹤0.01% |
+101,426
| New | +$226K |
|
|
FINL
1247
DELISTED
Finish Line
FINL
| $268K | ﹤0.01% |
+18,470
| New | +$199K |
|
|
ARA
1248
DELISTED
American Renal Associates Holdings, Inc
ARA
| $266K | ﹤0.01% |
+15,277
| New | +$211K |
|
1249
Heritage Financial
HFWA
$1.21B
| $264K | ﹤0.01% |
+8,573
| New | +$264K |
|
1250
Xencor
XNCR
$1.48B
| $263K | ﹤0.01% |
12,020
-174,013
| -94% | -$3.77M |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q4 2017 Portfolio in Review
As of Q4 2017, Marshall Wace North America held 1,826 positions worth $18.1B, up 14% from $15.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace North America deployed $1.49B of net new capital in Q4 2017, opening 616 new positions and adding to 338 existing holdings. Its largest new stake was Time Warner Inc: 2,188,772 shares worth $200M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Applied Materials, an estimated $162M trimmed.
- Marshall Wace North America's largest Q4 2017 buy was Time Warner Inc: 2,188,772 shares worth $200M.
- Marshall Wace North America added most to Boston Scientific in Q4 2017, an estimated $219M increase.
- Marshall Wace North America's biggest Q4 2017 reduction was Applied Materials, cutting an estimated $162M.
- Marshall Wace North America fully exited NVIDIA in Q4 2017, selling an estimated $75.7M.
- Marshall Wace North America's ten largest holdings make up 14% of its $18.1B portfolio in Q4 2017.
- Marshall Wace North America opened 616 new positions and closed 491 in Q4 2017.
- Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $18.1B.
Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.